|
1
|
Kennedy SG, Wagner AJ, Conzen SD, Jordan
J, Bellacosa A, Tsichlis PN and Hay N: The PI 3-kinase/Akt
signaling pathway delivers an anti-apoptotic signal. Genes Dev.
11:701–713. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Datta SR, Brunet A and Greenberg ME:
Cellular survival: a play in three Akts. Genes Dev. 13:2905–2927.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Finkel T and Holbrook NJ: Oxidants,
oxidative stress and the biology of ageing. Nature. 408:239–247.
2000. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Martindale JL and Holbrook NJ: Cellular
response to oxidative stress: signaling for suicide and survival. J
Cell Physiol. 192:1–15. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wada T and Penninger JM: Mitogen-activated
protein kinases in apoptosis regulation. Oncogene. 23:2838–2849.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Widmann C, Gibson S, Jarpe MB and Johnson
GL: Mitogen-activated protein kinase: conservation of a
three-kinase module from yeast to human. Physiol Rev. 79:143–180.
1999.PubMed/NCBI
|
|
7
|
Kyriakis JM and Avruch J: Mammalian MAPK
signal transduction patyhways activated by stress and inflammation:
a 10-year update. Physiol Rev. 92:689–737. 2012.PubMed/NCBI
|
|
8
|
Lewis TS, Shapiro PS and Ahn NG: Signal
transduction through MAP kinase cascades. Adv Cancer Res.
74:49–139. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu J, Suzuki H, Akhand AA, Zhou YW,
Hossain K and Nakashima I: Modes of activation of mitogen-activated
protein kinases and their roles in cepharanthine-induced apoptosis
in human leukemia cells. Cell Signal. 14:509–515. 2002. View Article : Google Scholar
|
|
10
|
Platanias LC: MAP kinase signaling
pathways and hematologic malignancies. Blood. 101:4667–4679. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shrode LD, Rubie EA, Woodgett JR and
Grinstein S: Cytosolic alkalinization increases stress-activated
protein kinase/c-Jun NH2-terminal kinase (SAPK/JNK)
activity and p38 mitogen-activated protein kinase activity by a
calcium-independent mechanism. J Biol Chem. 272:13653–13659.
1997.PubMed/NCBI
|
|
12
|
Raciti M, Lotti LV, Valia S, Pulcinelli FM
and Di Renzo L: JNK2 is activated during ER stress and promotes
cell survival. Cell Death Dis. 3:e4292012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Okamoto S, Krainc D, Sherman K and Lipton
SA: Antiapoptotic role of the p38 mitogen-activated protein
kinase-myocyte enhancer factor 2 transcription factor pathway
during neuronal differentiation. Proc Natl Acad Sci USA.
97:7561–7566. 2000. View Article : Google Scholar
|
|
14
|
Nakazato K and Hatano Y: Monensin-mediated
antiport of Na+ and H+ across liposome
membrane. Biochim Biophys Acta. 1064:103–110. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhu WH and Loh TT: Effects of
Na+/H+ antiport and intracellular pH in the
regulation of HL-60 cell apoptosis. Biochim Biophys Acta.
1269:122–128. 1995.
|
|
16
|
Park WH, Lee MS, Park K, Kim ES, Kim BK
and Lee YY: Monensin-mediated growth inhibition in acute
myelogenous leukemia cells via cell cycle arrest and apoptosis. Int
J Cancer. 101:235–242. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Park WH, Seol JG, Kim ES, et al:
Monensin-mediated growth inhibition in human lymphoma cells through
cell cycle arrest and apoptosis. Br J Haematol. 119:400–407. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Iljin K, Ketola K, Vainio P, et al:
High-throughput cell-based screening of 4910 known drugs and
drug-like small molecules identifies disulfiram as an inhibitor of
prostate cancer cell growth. Clin Cancer Res. 15:6070–6078. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ketola K, Hilvo M, Hyotylainen T, et al:
Salinomycin inhibits prostate cancer growth and migration via
induction of oxidative stress. Br J Cancer. 106:99–106. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sundstrom C and Nilsson K: Establishment
and characterization of a human histiocytic lymphoma cell line
(U-937). Int J Cancer. 17:565–577. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nicoletti I, Migliorati G, Pagliacci MC,
Grignani F and Riccardi C: A rapid and simple method for measuring
thymocyte apoptosis by propidium iodide staining and flow
cytometry. J Immunol Methods. 139:271–279. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cirone M, Di Renzo L, Lotti LV, et al:
Primary effusion lymphoma cell death induced by bortezomib and AG
490 activates dendritic cells through CD91. PLoS One. 7:e317322012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Matusali G, Arena G, De Leo A, Di Renzo L
and Mattia E: Inhibition of p38 MAP kinase pathway induces
apoptosis and prevents Epstein Barr virus reactivation in Raji
cells exposed to lytic cycle inducing compounds. Mol Cancer.
8:182009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Marfè G, Morgante E, Di Stefano C, Di
Renzo L, et al: Sorbitol-induced apoptosis of human leukemia is
mediated by caspase activation and cytochrome c release. Arch
Toxicol. 82:371–377. 2008.PubMed/NCBI
|
|
25
|
Morita I, Schindler M, Regier MK, Otto JC,
Hori T, DeWitt DL and Smith WL: Different intracellular locations
for prostaglandin endoperoxide H synthase-1 and -2. J Biol Chem.
270:10902–10908. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Davies SP, Reddy H, Caivano M and Cohen P:
Specificity and mechanism of action of some commonly used protein
kinase inhibitors. Biochem J. 351:95–105. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Smith WL, DeWitt DL and Garavito RM:
Cyclooxygenases: structural, cellular, and molecular biology. Annu
Rev Biochem. 69:145–182. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen W, Tang Q, Gonzales MS and Bowden GT:
Role of p38 MAPK and ERK in mediating ultraviolet-B induced
cyclooxygenase-2 gene expression. Oncogene. 20:3921–3926. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hung JH, Su IJ, Lei HY, et al: Endoplasmic
reticulum stress stimulates the expression of cyclooxygenase-2
through activation of NF-kappaB and pp38 mitogen-activated protein
kinase. J Biol Chem. 279:46384–46392. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rizzo MT, Pudlo N, Farrell L and Leaver A:
Specificity of arachidonic acid-induced inhibition of growth and
activation of c-jun kinases and p38 mitogen-activated protein
kinase in hematopoietic cells. Prostaglandins Leukot Essent Fatty
Acids. 66:31–40. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gauthier ML, Pickering CR, Miller CJ,
Fordyce CA, Chew KL, Berman HK and Tlsty TD: p38 regulates
cyclooxygenase-2 in human mammary epithelial cells and is activated
in premalignant tissue. Cancer Res. 65:1792–1799. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hendrickx N, Volanti C, Moens U, et al:
Up-regulation of cyclooxygenase-2 and apoptosis resistance by p38
MAPK in hypericin-mediated photodynamic therapy of human cancer
cells. J Biol Chem. 278:52231–52239. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang XD, Kiang JG, Scheibel LW and
Smallridge RC: Phospholipase C activation by
Na+/Ca2+ exchange is essential for
monensin-induced Ca2+ influx and arachidonic acid
release in FRTL-5 thyroid cells. J Investig Med. 47:388–396.
1999.PubMed/NCBI
|
|
34
|
Smith WL and Langenbach R: Why there are
two cyclooxygenase isozymes. J Clin Invest. 107:1491–1495. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Reddy BS, Rao CV and Seibert K: Evaluation
of cyclooxygenase-2 inhibitor for potential chemopreventive
properties in colon carcinogenesis. Cancer Res. 56:4566–4569.
1996.PubMed/NCBI
|
|
36
|
Tsujii M, Kawano S and DuBois R:
Cyclooxygenase-2 expression in human colon cancer cells increases
metastatic potential. Proc Natl Acad Sci USA. 94:3336–3340. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Oshima M, Dinchuk JE, Kargman SL, et al:
Suppression of intestinal polyposis in Apc delta716 knockout mice
by inhibition of cyclooxygenase 2 (COX-2). Cell. 87:803–809. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wolff H, Saukkonen K, Anttila S,
Karjalainen A, Vainio H and Ristimaki A: Expression of
cyclooxygenase-2 in human lung carcinoma. Cancer Res. 58:4997–5001.
1998.PubMed/NCBI
|
|
39
|
Chan G, Boyle JO, Yang EK, Zhang F, et al:
Cyclooxygenase-2 expression is up-regulated in squamous cell
carcinoma of the head and neck. Cancer Res. 59:991–994.
1999.PubMed/NCBI
|
|
40
|
Higashi Y, Kanekura T and Kanzaki T:
Enhanced expression of cyclooxygenase (COX)-2 in human skin
epidermal cancer cells: evidence for growth suppression by
inhibiting COX-2 expression. Int J Cancer. 86:667–671. 2000.
View Article : Google Scholar : PubMed/NCBI
|
